Stryker Sees ‘V-Shape’ Recovery In Third Quarter
Led by the Mako surgical robot, Stryker’s third-quarter sales exceeded Wall Street analysts’ expectations as it prepares to complete the $4bn acquisition of Wright Medical.
You may also be interested in...
The agreements with the US Federal Trade Commission and the UK Competition and Markets Authority are the last regulatory hurdles in the way of Stryker’s planned $4bn acquisition of Wright Medical.
Many changes have come about for the orthopedic innovator Stryker as a result of the pandemic, says group CEO Kevin Lobo. The most important relates to methods of engagement with customers.
Surgical volumes are rebounding close to pre-pandemic levels, but the volumes at hospitals may never completely rebound, according to medtech CEOs participating in a discussion at The Virtual MedTech Conference.